CVE-2014-0370
Unspecified vulnerability in the Siebel Life Sciences component in Oracle Siebel CRM 8.1.1 and 8.2.2 allows remote authenticated users to affect availability via unknown vectors related to Clinical Trip Report.
Does this matter?
Lower severity and a low EPSS score (1.26%). Track it; it rarely justifies an emergency change on its own.
Description
Unspecified vulnerability in the Siebel Life Sciences component in Oracle Siebel CRM 8.1.1 and 8.2.2 allows remote authenticated users to affect availability via unknown vectors related to Clinical Trip Report.
- CVSS 2.0
- 2.8 LOWAV:N/AC:M/Au:M/C:N/I:N/A:P
- EPSS
- 1.26% probability · 69th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Affected
- oracle/siebel crm
- Source
- secalert_us@oracle.com
EPSS 1.3% since 26 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
References
- http://osvdb.org/102108
- http://secunia.com/advisories/56481
- http://www.oracle.com/technetwork/topics/security/cpujan2014-1972949.htmlVendor Advisory
- http://www.securityfocus.com/bid/64758
- http://www.securityfocus.com/bid/64837
- http://www.securitytracker.com/id/1029622
- http://osvdb.org/102108
- http://secunia.com/advisories/56481
- http://www.oracle.com/technetwork/topics/security/cpujan2014-1972949.htmlVendor Advisory
- http://www.securityfocus.com/bid/64758
- http://www.securityfocus.com/bid/64837
- http://www.securitytracker.com/id/1029622
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.